Purpose. Uric acid is known to impair endothelial cell function and to stimulate the development of renal interstitial fibrosis. The aim of this study was to evaluate the association between first-year hyperuricemia with graft dysfunction and the development of cardiovascular risk disorders in renal transplant recipients. Methods. One hundred kidney transplant recipients (31 female, 45.9 +/- 9.6 post-transplantation months) with normal graft functions were enrolled. The clinical biochemical parameters in the first post-transplantation year were retrospectively recorded and searched for the predictive value in yearly determined graft function and association with cross-sectionally analyzed cardiovascular parameters, including body composition analyses, ambulatory blood pressure monitoring data, and pulse wave velocity. Hyperuricemia was defined as an uric acid level of >= 6.5 mg/dL that persisted for at least 2 consecutive tests. Results. One year after transplantation, 37% of subjects had hyperuricemia. According to cross-sectional data, sagittal abdominal diameter (P = .002) and hip circumferences (P = .013) were significantly higher in hyperuricemic patients than in normouricemic ones. Hyperuricemic patients had higher fat (P = .014) and muscle mass (P = .016) than normouremic patients. Hyperuricemic patients had significantly higher mean systolic BP (P = .044) than normouremic patients. Hyperuricemic patients had significantly higher pulse wave velocity levels (P = .0001) and left ventricular mass index (P = .044) than normouremic patients. The yearly decline in estimated glomerular filtration rate levels was significantly higher in hyperuricemic patients (P = .0001) than in normouricemic ones. Conclusion. Post-transplantation hyperuricemia is associated with hypertension, arterial stiffness, and dyslipidemia; it should be accepted not only as a marker for renal allograft dysfunction but also as a cardiovascular risk factor in renal transplant recipients.
机构:
Vanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, 221 Kirkland Hall, Nashville, TN 37235 USAVanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, 221 Kirkland Hall, Nashville, TN 37235 USA
Birdwell, Kelly A.
Park, Meyeon
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Div Nephrol, Dept Med, San Francisco, CA 94143 USAVanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, 221 Kirkland Hall, Nashville, TN 37235 USA
Park, Meyeon
[J].
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2021,
16
(12):
: 1878
-
1889